BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 11380073)

  • 1. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice.
    Tsuchida A; Nakagawa T; Itakura Y; Ichihara J; Ogawa W; Kasuga M; Taiji M; Noguchi H
    Diabetologia; 2001 May; 44(5):555-66. PubMed ID: 11380073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice.
    Yamanaka M; Tsuchida A; Nakagawa T; Nonomura T; Ono-Kishino M; Sugaru E; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Jan; 9(1):59-64. PubMed ID: 17199719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.
    Nakagawa T; Ono-Kishino M; Sugaru E; Yamanaka M; Taiji M; Noguchi H
    Diabetes Metab Res Rev; 2002; 18(3):185-91. PubMed ID: 12112936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation.
    Igarashi R; Nakayama T; Takenaga M; Ichinohe M; Yamaguchi Y; Matsumoto K; Kitagawa A; Nakamura N; Kawai S; Nakagawa T; Taiji M; Nakayama C; Mizushima Y
    J Control Release; 2005 Feb; 102(2):463-73. PubMed ID: 15653164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.
    Yamanaka M; Itakura Y; Ono-Kishino M; Tsuchida A; Nakagawa T; Taiji M
    J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice.
    Tsuchida A; Nonomura T; Ono-Kishino M; Nakagawa T; Taiji M; Noguchi H
    Int J Obes Relat Metab Disord; 2001 Sep; 25(9):1286-93. PubMed ID: 11571589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice.
    Ono M; Ichihara J; Nonomura T; Itakura Y; Taiji M; Nakayama C; Noguchi H
    Biochem Biophys Res Commun; 1997 Sep; 238(2):633-7. PubMed ID: 9299565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation.
    Moon B; Kwan JJ; Duddy N; Sweeney G; Begum N
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E106-15. PubMed ID: 12618360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin.
    Kim YB; Uotani S; Pierroz DD; Flier JS; Kahn BB
    Endocrinology; 2000 Jul; 141(7):2328-39. PubMed ID: 10875232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
    Chen WY; Chen CJ; Liu CH; Mao FC
    Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes.
    Yea K; Kim J; Lim S; Kwon T; Park HS; Park KS; Suh PG; Ryu SH
    Biochem Biophys Res Commun; 2009 Jan; 378(4):783-8. PubMed ID: 19063864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity in streptozotocin-induced diabetic rats treated with different doses of 17beta-oestradiol or progesterone.
    Ordóñez P; Moreno M; Alonso A; Fernández R; Díaz F; González C
    Exp Physiol; 2007 Jan; 92(1):241-9. PubMed ID: 17068109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
    Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
    Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice.
    Nonomura T; Tsuchida A; Ono-Kishino M; Nakagawa T; Taiji M; Noguchi H
    Int J Exp Diabetes Res; 2001; 2(3):201-9. PubMed ID: 12369708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
    Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM
    Nature; 2001 Sep; 413(6852):131-8. PubMed ID: 11557972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.
    Nakagawa T; Tsuchida A; Itakura Y; Nonomura T; Ono M; Hirota F; Inoue T; Nakayama C; Taiji M; Noguchi H
    Diabetes; 2000 Mar; 49(3):436-44. PubMed ID: 10868966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
    Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.